Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1136/annrheumdis-2019-215183

Type

Journal article

Journal

Ann rheum dis

Publication Date

10/2019

Volume

78

Pages

1439 - 1441

Keywords

dmards (biologic), rheumatoid arthritis, ultrasonography, Adalimumab, Adult, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Rheumatoid, Female, Humans, Joints, Male, Middle Aged, Neovascularization, Pathologic, Severity of Illness Index, Ultrasonography, Doppler